V
VERA THERAPEUTICS INC
NASDAQ: VERA (Vera Therapeutics, Inc.)
最近更新时间: 3小时之前33.60
-0.18 (-0.53%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看涨 |
| Biotechnology (全球的) | 混合的 | 看涨 | |
| 股票 | Vera Therapeutics, Inc. | 混合的 | 看涨 |
AIStockmoo 评分
1.3
| 分析师共识 | NA |
| 内部交易活动 | -1.5 |
| 价格波动 | 2.0 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | 2.0 |
| 平均 | 1.25 |
|
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Growth |
| 内部持股比例 | 3.97% |
| 机构持股比例 | 112.39% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Avoro Capital Advisors Llc | 30 Jun 2026 | 5,723,888 |
| Deep Track Capital, Lp | 30 Jun 2026 | 4,000,000 |
| Kynam Capital Management, Lp | 30 Jun 2026 | 2,890,059 |
| Sofinnova Investments, Inc. | 30 Jun 2026 | 2,793,987 |
| Eversept Partners, Lp | 30 Jun 2026 | 2,212,770 |
| Integral Health Asset Management, Llc | 30 Jun 2026 | 1,750,000 |
该时间范围内无数据。
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| FORDYCE MARSHALL | - | 35.66 | -18,500 | -659,710 |
| 累积净数量 | -18,500 | |||
| 累积净值 ($) | -659,710 | |||
| 累积平均购买 ($) | - | |||
| 累积平均卖出 ($) | 35.66 | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| FORDYCE MARSHALL | 职员 | 02 Sep 2026 | 自动卖出 (-) | 18,500 | 35.66 | 659,710 |
| FORDYCE MARSHALL | 职员 | 02 Sep 2026 | 执行期权 | 18,500 | - | - |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合